Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8135
Reference
MSAN(2024)19
Name
Cefalexin 125mg/5ml and 250mg/5ml oral suspension
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Health Boards
Pharmaceutical Services
Supplies
Drug Shortages
Description
Cefalexin 125mg/5ml oral suspension is out of stock from mid-April until early July 2024.
Cefalexin 250mg/5ml oral suspension is out of stock from late-April until early July 2024.
Cefalexin 250mg tablets are out of stock until early May 2024.
Cefalexin 250mg and 500mg capsules remain available and can support an increase in demand.
Cefalexin 500mg tablets remain available and can support an increase in demand.
Cefaclor (Distaclor®) 125mg/5ml and 250mg/5ml oral suspensions remain available but can only support a partial uplift in demand.
Cefuroxime (Zinnat®) 125mg/5ml oral suspension remains available and can support an increase in demand.
Alternative liquid formulations of antibiotics remain available.
Contact Name
Contact Email
Contact Address
Created
2024-05-09 08:47:00
Click to go back to homepage